AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BUSINESS BRIEFS.(TO THE POINT)
MEDICAL
Stent maker's sales recovering
Boston Scientific, whose recall of Taxus heart stents pummeled its stock over the summer, said it's already recovered lost market share. While sales of the drug-coated stents, which help prop open arteries, slowed in August, they gained market share. By month's end, the company again controlled 70% of the market vs. 56% in July. It estimated the recall cost $100 mil. News overshadowed Q3 and Q4 forecasts below Wall Street estimates. Shares rose 7% to 38.28.
MGI Pharma lifts SuperGen
MGI Pharma shot up 20% to 27.85 after it said it will spend up to $85 mil to develop and sell SuperGen's experimental cancer drug Dacogen. MGI Pharma is making a $40 mil equity investment in the biotech at $10 a share, and will pay up to $45 mil as regulatory and commercial milestones are reached. SuperGen rose 8% to 6.94.
Glaxo posts trial results online
The drug firm has posted summaries of clinical trials for the diabetes drug Avandia in its new online registry, days after GlaxoSmithKline agreed to pay $2.5 mil and release ...
- MGI PHARMA Secures Equity Financing Facility.
- Press release article from: PR Newswire March 1, 2001 700+ words
...MINNEAPOLIS, March 1 /PRNewswire/ -- MGI PHARMA, INC. (Nasdaq: MOGN) today...Ramius Securities will place, at MGI PHARMA's election from time to time, an aggregate of up to $100 million of MGI PHARMA common stock over a two-year period...
- MGI PHARMA to Present at the UBS 2005 Global Life Sciences Conference.
- Press release article from: Business Wire September 20, 2005 700+ words
MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) today announced...president and chief executive officer of MGI PHARMA, will give the presentation, which...New York in New York City. What: MGI PHARMA's presentation at the UBS 2005 Global...
- MGI PHARMA and SuperGen Announce Signing of a Worldwide License Agreement for...
- Press release article from: PR Newswire September 1, 2004 700+ words
MGI PHARMA, INC. , and SuperGen, Inc. , today...signed a definitive agreement granting MGI PHARMA exclusive worldwide rights to the development...Under the terms of this agreement, MGI PHARMA will make a $40 million equity investment...
- MGI PHARMA Announces Commencement of Tender Offer for Guilford Pharmaceutical...
- Press release article from: Business Wire October 20, 2005 700+ words
MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) announces...and 401829AB2 (the "Notes")). MGI PHARMA is making the offer together with...Pharmaceuticals Inc. As a result of MGI PHARMA's acquisition of Guilford Pharmaceuticals...
- MGI PHARMA And Alpharma Enter into Promotion Agreement for Kadian in Cancer...
- Press release article from: Business Wire July 14, 2004 700+ words
MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN), an oncology...terms of this promotion agreement, MGI PHARMA will market Kadian in the United States...president and chief executive officer of MGI PHARMA. "We believe Kadian is an excellent...
- MGI PHARMA to Acquire Guilford Pharmaceuticals.
- Press release article from: Business Wire July 21, 2005 700+ words
...MINNEAPOLIS & BALTIMORE -- MGI PHARMA, INC. (Nasdaq: MOGN): --Strategic Combination Strengthens MGI PHARMA's Oncology Franchise and Significantly...Further Discuss This Transaction-- MGI PHARMA, INC. (Nasdaq: MOGN), an oncology...
- MGI PHARMA and MethylGene Sign License, Research and Development Agreement For...
- Press release article from: PR Newswire August 3, 2000 700+ words
...MONTREAL, Aug. 3 /PRNewswire/ -- MGI PHARMA, INC. (Nasdaq: MOGN), and MethylGene...trial makes MG98 an important addition to MGI PHARMA's portfolio of anti-cancer agents...president, research and development of MGI PHARMA. "In addition, we are impressed by...
- MGI PHARMA and SuperGen Announce Signing of a Worldwide License Agreement for...
- Press release article from: Business Wire September 1, 2004 700+ words
...MINNEAPOLIS & DUBLIN, Calif. -- MGI PHARMA, INC. (Nasdaq:MOGN) and SuperGen...signed a definitive agreement granting MGI PHARMA exclusive worldwide rights to the development...Under the terms of this agreement, MGI PHARMA will make a $40 million equity investment...